New rules for the access and use of veterinary drugs

Health Canada is changing regulations and policies regarding the access and use of medically important antimicrobials in animals.

Antimicrobials used in human and animal health are categorized by Health Canada according to their importance in human medicine. There are four categories based on whether an antimicrobial is used as the preferred treatment option for serious human infections and whether there are treatment alternatives available. Categories 1, 2 and 3 are considered medically important antimicrobials (MIA).

As of December 1, 2018, all medically important antimicrobials will have prescription status and only be available from your veterinarian, or pharmacy.

Commonly used medically important antimicrobial active ingredients used to treat pigs are:

  • Apramycin
  • Bacitracin
  • Erythromycin
  • Lincomycin
  • Neomycin
  • Penicillin G
  • Spectinomycin
  • Streptomycin-Dihydrostreptomycin
  • Sulphonamides
  • Tilmicosin
  • Tiamulin
  • Tylosin-Tylvalosin
  • Virginiamycin
  • Tetracycline-Chlortetracycline-Oxy-Tetracycline  

Products containing these ingredients will require a prescription as of December 1, 2018.

Pork producers with a valid prescription will be able to purchase drugs (including drugs that may be mixed into animal feed) at a veterinary clinic or a pharmacy. Prescription medicated feed can be purchased through a veterinarian, a pharmacist or a commercial feed mill with a valid veterinary prescription.

In order to use medically important antimicrobials in the care of animals, veterinarians will need to have a valid Veterinary-Client-Patient-Relationship with the animal owner to issue a prescription.

A Veterinary-Client-Patient-Relationship is a medical service relationship between the veterinarian and the farmer for the care of food animals and is regulated by provincial veterinary licensing authorities.

According to the Canadian Veterinary Medical Association, a legitimate VCPR is considered to exist only if medical records of the veterinary practice contain evidence of relevant and timely interaction between the veterinarian, animal owner and animal patients. This may include: farm visits, consultations, direct animal examinations (individual or herd), laboratory reports, production record reviews, etc.

The VCPR is not a signed contractual agreement but rather a working connection and interaction between veterinarian, client and specific animal patient or group of animals. More information about the VCPR can be found at: www.canadianveterinarians.net/documents/importance-of-vcpr


Changes also impact medicated feed

 

Health Canada intends to include all the approved in-feed drug products, including prescription drugs, in the Compendium of Medicated Ingredient Brochures. A veterinary prescription will be required prior to the sale of medicated feed containing a prescription drug.

 

The Compendium of Medicated Ingredients Brochure, maintained by the Canadian Food Inspection Agency, is an important resource for feed mills, veterinarians and producers, as it provides instructions on how to manufacture medicated feeds and directions for use.


Updating of medically important antimicrobials product labels

 

Animal health product manufacturers will be updating MIA product labels, where applicable, to remove growth promotion claims, update therapeutic claims, add responsible use statements for in-feed and in-water products, along with adding a new responsible use logo. The logo will make these products easier to identify and reflects the animal pharmaceutical industry’s commitment to antimicrobial stewardship.


Medically important antimicrobials may no longer be imported into Canada by individuals

 

As of November 13, 2017, the own use importation of medically important antimicrobials for veterinary use will no longer be permitted. List B, under the Food and Drug Regulations, will identify those products that are not MIA for which farmers can still import licensed, finished product from another country with a recognized, competent regulatory authority.

The responsible use of antimicrobial drugs, such as antibiotics, will minimize the development and spread of antimicrobial resistance, and preserve the effectiveness of these drugs to combat bacterial infections. We all have a role to play.

For more information: